Sub-Nanomolar hMC1R agonists by end-capping of the melanocortin tetrapeptide His-D-Phe-Arg-Trp-NH2

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 16, 2003, Pages 2647-2650

  Koikov, L N ^a   Ebetino, F H ^b   Solinsky, M G ^b   Cross Doersen, D ^b   Knittel, J J ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLIC ACID; HISTIDINE; HISTIDYL DEXTRO PHENYLALANYLARGINYLTRYPTOPHANAMIDE; HORMONE RECEPTOR STIMULATING AGENT; LK 184; MELANOCORTIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 1 RECEPTOR AGONIST; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; RECEPTOR SUBUNIT; SULFONIC ACID DERIVATIVE; TETRAPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CAPPING PHENOMENON; DRUG ACTIVITY; DRUG DESIGN; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 0037811382     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00552-3     Document Type: Article

References (21)

1. The Melanocortin Receptors. Cone, R. D., Ed. Humana: Totowa, 2000.
2. Hruby V.J., Wilkes B.C., Cody W.L., Sawyer T.K., Hadley M.E. Peptide and Protein Rev. 3:1984;1.
3. Mountjoy K.G., Robbins L.S., Mortrud M.T., Cone R.D. Science. 257:1992;1248.
4. Lu D., Väge D.I., Cone R.D. Mol. Endocr. 12:1998;592.
5. Chen A.S., Marsh D.J., Trumbauer M.E., Frazier E.G., Guan X.M., Yu H., Rosenblum C.I., Vongs A., Feng Y., Cao L., Metzeger J.M., Strack A.M., Camacho R.E., Mellin T.N., Nunes C.N., Min W., Fischer J., Gopal-Truter S., MacIntyre D.E., Chen H.Y., Van der Ploeg L.H. Nat. Genet. 26:2000;97.
6. Butler A.A., Kesterson R.A., Khong K., Cullen M.J., Pelleymounter M.A., Dekoning J., Baetscher M., Cone R.D. Endocrinology. 141:2000;3518.
7. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Smith F.J., Kesterson R.A., Boston B.A., Fang Q., Berkemeir L.R., Gu W., Cone R.D. Cell. 88:1997;131.
8. Hruby V.J., Wilkes B.C., Hadley M.E., Al-Obeidi F., Sawyer T.K., Staples D.J., DeVaux A., Dym O., Castrucci A.M., Hintz M.F., Riehm J.P., Rao K.R. J. Med. Chem. 30:1987;2126.
9. Castrucci A.M., Hadley M.E., Sawyer T.K., Wilkes B.C., Al-Obeidi F., Staples D.J., DeVaux A., Dym O., Hintz M.F., Riehm J.P., Rao K.R.J., Hruby V.J. Gen. Comp. Endocrinol. 73:1989;157.
10. Haskell-Luevano C., Sawyer T.K., Hendrata S., North C., Panahinia L., Stum M., Staples D.J., Castrucci A.M., Hadley M.E., Hruby V.J. Peptides. 17:1996;995.
11. Sawyer T.K., Sunfilippo P.J., Hruby V.J., Engel V.J., Heward C.B., Burnett J.B., Hadley M.E. Proc. Natl. Acad. Sci. U.S.A. 77:1980;5754.
12. Al-Obeidi F., de Castrucci L., Hadley M.E., Hruby V.J. J. Med. Chem. 32:1989;2555.
13. Bednarek M.A., MacNeil T., Kalyani R.N., Tang R., Van der Ploeg L.H.T., Weinberg D.H. Biochem. Biophys. Res. Comms. 261:1999;209.
14. Bednarek M.A., Silva M.V., Arison B., MacNeil T., Kalyani R.N., Huang R.-R.C., Weinberg D.H. Peptides. 20:1999;401.
15. Prusis P., Muceniece R., Mutule I., Mutulis F., Wikberg J.E.S. Eur. J. Med. Chem. 36:2001;137.
16. Yang Y.K., Fong T.M., Dickinson C.J., Mao C., Li J.-Y., Tota M.R., Mosley R., Van der Ploeg L.H.T., Gantz I. Biochem. 39:2000;14900.
17. Haskell-Luevano C., Holder J.R., Monck E.K., Bauzo R.M. J. Med. Chem. 44:2001;2247.
18. Koikov, L. N.; Knittel, J. J.; Solinsky, M. G.; Cross-Doersen D.; Ebetino F. H. Abstracts of Papers, 224 National Meeting of the American Chemical Society, Boston, MA; American Chemical Society: Washington, DC, 2002; Abstract 337.
19. Marques, F. F.; Holder, J. R.; Bauzo, R.; Xiang, Z. and Haskell-Luevano, C. Abstracts of Papers, 223 National Meeting of the American Chemical Society, Orlando, FL; American Chemical Society: Washington, DC, 2002; Abstract 74.
20. Holder J.R., Marques F.F., Xiang Z., Bauzo R., Haskell-Luevano C. Eur. J. Pharm. 462:2003;41.
21. Cheung A.W.-H., Danho W., Swistok J., Qi L., Kurylko G., Franco L., Yagaloff K.A., Chen L. Bioorg. Med. Chem. Lett. 12:2002;2407.